Jazz Pharmaceuticals plc: Jazz Pharmaceuticals to Present New Data at SLEEP 2022 Reinforcing Leadership in Sleep Medicine
Seventeen abstracts debut new data across narcolepsy and idiopathic hypersomnia DUBLIN, June 1, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company
United States Kristin Bhavnani Kelvin Tan Andrean Flynn Jazz Pharmaceuticals Inc Jazz Pharmaceuticals
Source: finanznachrichten.de